Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
StrideBio
AddedFeb 15, 2024
UpdatedJun 18, 2026
StrideBio

StrideBio

Series B

StrideBio, Inc. is a US-based gene therapy company, specializing in genetic medicines for rare monogenic diseases.

HQ
Durham, NC, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

StrideBio, Inc. is a US-based gene therapy company dedicated to developing genetic medicines for rare monogenic diseases. The company's mission is to create best-in-class gene therapies for individuals with life-threatening conditions. StrideBio aims to lead the evolution of gene therapy through superior drug development, high industry standards, and extraordinary integrity, driven by an innovative team that translates scientific advancements into life-prolonging treatments.

StrideBio has made significant strides in the field of genetic medicine, focusing on pioneering therapies that address unmet medical needs. The company's commitment to excellence and innovation has positioned it as a key player in the gene therapy landscape. Through its cutting-edge research and development efforts, StrideBio continues to impact the lives of patients with rare genetic disorders, contributing to the advancement of medical science and therapeutic options.

StrideBio - Similar Companies

Strm.Bio logo

Strm.Bio

strm.bio

BridgeBio Pharma logo

BridgeBio Pharma

bridgebio.com

Strykagen logo

Strykagen

Solid Biosciences logo

Solid Biosciences

solidbio.com

Code Biotherapeutics logo

Code Biotherapeutics

codebiotx.com

ElevateBio logo

ElevateBio

Generation Bio logo

Generation Bio

generationbio.com

Locanabio logo

Locanabio

Rampart Bioscience logo

Rampart Bioscience

rampartbio.com

Regenxbio logo

Regenxbio

regenxbio.com

Apic Bio logo

Apic Bio

Limelight Bio logo

Limelight Bio

BridGene Biosciences logo

BridGene Biosciences

Stealth BioTherapeutics logo

Stealth BioTherapeutics

stealthbt.com

Krystal Biotech logo

Krystal Biotech

krystalbio.com

StrideBio - Quick Facts

Who are StrideBio's competitors?

Companies similar to StrideBio include Strm.Bio, BridgeBio Pharma, Strykagen and Solid Biosciences.

When was StrideBio founded?

StrideBio was founded in 2015.

Where is StrideBio's headquarters located?

StrideBio's headquarters is located in Durham, NC, US.

When was StrideBio's last funding round?

StrideBio's most recent funding round was for $81.5M (USD) in March 2021.

How much has StrideBio raised to-date?

As of Mar 16, 2021, StrideBio has raised a total of $97.2M (USD).

How many employees does StrideBio have?

StrideBio has 76 employees as of Feb 5, 2024.

StrideBio - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Gene Therapy
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified